Enterococcus spp. are common but not predominant commensal bacteria that inhabit the gastrointestinal tracts of humans and animals and are widely distributed in various environmental matrices and diverse food sources. Multiple strains of beneficial enterococci are increasingly utilized as protective cultures, alternatives to antibiotics, and probiotics for controlling pathogens, mitigating disease, modulating the microbiome, and supporting overall host health. They also support food fermentation and safety, enhance sensory properties, and produce bioactive compounds such as bacteriocins with strong pathogen-inhibitory activity and multifarious health benefits. Despite their advantages in health and agrifood systems, their association with healthcare-associated infections and the spread of antimicrobial resistance raises concerns about their safety. These risks underscore the need for stringent safety evaluations before their use as probiotics, alternatives to antibiotics, or protective cultures. Here, we provide a comprehensive atlas of the multifaceted probiotic and antimicrobial potential, as well as safety considerations of beneficial enterococci. This would provide a valuable resource for future research, regulatory assessments, and applications in the agrifood system and healthcare.
John et al. (Thu,) studied this question.